Keyphrases
Virus
100%
Potential Consequences
100%
SARS-CoV-2 Variants
100%
Spike Protein
66%
COVID-19
66%
SARS-CoV-2 VOCs
66%
VOC 202012/01
66%
United Kingdom
33%
South Africa
33%
Global Concern
33%
Nigeria
33%
Transmissibility
33%
Angiotensin-converting Enzyme 2 (ACE2)
33%
Clinical Characteristics
33%
2 Receptor
33%
New Infections
33%
Vaccine Development
33%
Epidemiological Characteristics
33%
P681H
33%
Genomic Surveillance
33%
N501Y mutant
33%
Epidemiological Surveillance
33%
Diagnostics Development
33%
Virologic
33%
Therapeutic Development
33%
S Gene
33%
Molecular Arms Race
33%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Infection
16%
Dipeptidyl Carboxypeptidase
16%
Arm
16%
Diagnosis
16%
Receptor
16%
Vaccine Development
16%
Epidemiological Surveillance
16%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Receptor
16%
Infection
16%
Dipeptidyl Carboxypeptidase
16%
Vaccine Development
16%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike
33%
Arm
16%
Neuroscience
SARS Coronavirus
100%
Dipeptidyl Carboxypeptidase
16%
Receptor
16%